These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1409411)

  • 21. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
    Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA; Mentink MM; Oetting WS
    Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.
    King RA; Townsend D; Oetting W; Summers CG; Olds DP; White JG; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
    Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The shift from physiological genetics to molecular genetics in the study of mouse tyrosinase.
    Quevedo WC; Holstein TJ
    Pigment Cell Res; 1992; Suppl 2():57-60. PubMed ID: 1409439
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
    Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA
    J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12.
    Ramsay M; Colman MA; Stevens G; Zwane E; Kromberg J; Farrall M; Jenkins T
    Am J Hum Genet; 1992 Oct; 51(4):879-84. PubMed ID: 1415228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.
    Chaki M; Sengupta M; Mukhopadhyay A; Subba Rao I; Majumder PP; Das M; Samanta S; Ray K
    Ann Hum Genet; 2006 Sep; 70(Pt 5):623-30. PubMed ID: 16907708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical spectrum of albinism in humans.
    Oetting WS; Brilliant MH; King RA
    Mol Med Today; 1996 Aug; 2(8):330-5. PubMed ID: 8796918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
    Shimizu H
    Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2).
    Manga P; Orlow SJ
    J Dermatol; 1999 Nov; 26(11):738-47. PubMed ID: 10635616
    [No Abstract]   [Full Text] [Related]  

  • 32. One-allele system in the Korean for MboI-RFLP in exon 1 of the human tyrosinase (TYR) gene.
    Kim DK; Kang KH; Choi IJ
    J Dermatol Sci; 2000 Sep; 24(1):1-3. PubMed ID: 10960773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.
    Spritz RA; Strunk KM; Hsieh CL; Sekhon GS; Francke U
    Am J Hum Genet; 1991 Feb; 48(2):318-24. PubMed ID: 1899321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel human pathological mutations. Gene symbol: TYR. Disease: albinism, oculocutaneous 1.
    Saxena R; Verma IC
    Hum Genet; 2010 Apr; 127(4):488. PubMed ID: 21491618
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular basis of oculocutaneous albinism.
    Oetting WS; King RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nature of tyrosinase isozymes.
    Tsukamoto K; Jiménez M; Hearing VJ
    Pigment Cell Res; 1992; Suppl 2():84-9. PubMed ID: 1409443
    [No Abstract]   [Full Text] [Related]  

  • 37. DNA-based carrier detection and prenatal diagnosis of tyrosinase-negative oculocutaneous albinism (OCA1A).
    Falik-Borenstein TC; Holmes SA; Borochowitz Z; Levin A; Rosenmann A; Spritz RA
    Prenat Diagn; 1995 Apr; 15(4):345-9. PubMed ID: 7617575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel human pathological mutations. Gene symbol: TYR. Disease: Albinism, oculocutaneous 1.
    Saxena R; Verma IC
    Hum Genet; 2010 Apr; 127(4):488. PubMed ID: 21491619
    [No Abstract]   [Full Text] [Related]  

  • 39. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
    J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.